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Substance misuse teaching in undergraduate
medical education
Janine Carroll1*†, Christine Goodair2†, Andrew Chaytor3†, Caitlin Notley4†, Hamid Ghodse2† and Peter Kopelman5†
Abstract
Background: Over 12,000 hospital admissions in the UK result from substance misuse, therefore issues surrounding
this need to be addressed early on in a doctor’s training to facilitate their interaction with this client group.
Currently, undergraduate medical education includes teaching substance misuse issues, yet how this is formally
integrated into the curriculum remains unclear.
Methods: Semi-structured interviews with 17 key members of staff responsible for the whole or part of the
undergraduate medical curriculum were conducted to identify the methods used to teach substance misuse. Using
a previously devised toolkit, 19 curriculum co-ordinators then mapped the actual teaching sessions that addressed
substance misuse learning objectives.
Results: Substance misuse teaching was delivered primarily in psychiatry modules but learning objectives were also
found in other areas such as primary care placements and problem-based learning. On average, 53 teaching
sessions per medical school focused on bio-psycho-social models of addiction whereas only 23 sessions per medical
school focused on professionalism, fitness to practice and students’ own health in relation to substance misuse.
Many sessions addressed specific learning objectives relating to the clinical features of substance dependence
whereas few focused on iatrogenic addiction.
Conclusions: Substance misuse teaching is now inter-disciplinary and the frequent focus on clinical, psychological
and social effects of substance misuse emphasises the bio-psycho-social approach underlying clinical practice. Some
areas however are not frequently taught in the formal curriculum and these need to be addressed in future
changes to medical education.
Background
Substance misuse is a major public health issue in the
UK, with 36.5% of 16 to 59 year old adults in England
and Wales taking illicit drugs throughout their lifetime
[1]. Furthermore, children as young as 11 years of age are
smoking, drinking alcohol or taking drugs [2]. The impact
this has on healthcare systems is profound; 12,344 re-
ported hospital admissions in England were the result of
drug poisoning with drug-related mental health and be-
havioural disorders also featuring in hospital admissions
[1]. Currently, the Department of Health, UK, is address-
ing the issues related to substance misuse by focusing on
the treatment of drug users and the supply of/demand for
drugs [3]. However, substance misuse remains a major
public health concern.
It is necessary to ensure health professionals are
equipped with the skills required to help treat and man-
age people who misuse substances. General practitioners
(GP) are often amongst the first health professionals to
diagnose people with a substance misuse problem, yet
these discussions between patient and GP often focus
primarily on tobacco and alcohol use and can often be
difficult for both participants to discuss [4]. This sug-
gests that substance misuse problems can be missed by
the doctor during consultations. Furthermore, additional
complications may arise for the doctor if the patient is a
colleague or other healthcare professional. Although
doctors may have similar rates of alcohol misuse as the
general population, their high use of prescription drugs
as a form of self-treatment is widely recognised and col-
leagues can be unwilling to intervene if this use becomes
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problematic [5]. Additionally, substance misuse can have
an impact on doctors’ fitness to continue practising in clin-
ical environments. Addressing these issues at an early stage
of medical training therefore is essential.
Substance misuse topics in medical education predom-
inately focus on the effects of smoking or alcohol con-
sumption with less information regarding legal and
illegal drugs. O’Brien and Cullen found that despite in-
creases in the prevalence of substance misuse, there had
been no increase in the time allocated to teach under-
graduate medical students substance misuse topics in
Ireland [6]. An average of 6 hours of formal substance
misuse training has been reported by medical schools in
the UK and is mainly conducted within psychiatry and
public health modules [7,8]. However, this does not ac-
count for the learning that occurs in the informal teach-
ing environment or via the hidden curriculum, both of
which are influential in shaping students’ learning and
subsequent interaction with patients [9]. Since medical
students have unique experiences influenced by their in-
formal learning, it is important that medical education
addresses the disparity between the amount of formal
teaching and future clinical exposure to substance mis-
use issues to ensure that all students are provided with
some formal education in this area.
Recommendations for core medical competencies on
alcohol and other drugs have been made for postgradu-
ate curricula for all doctors. A working group from the
medical Royal Colleges published a report in 2012 which
suggested that postgraduate medical curricula should
consider incorporating learning objectives such as identi-
fying the effects of using drugs, identifying the long-term
implications of using drugs and being able to become
confident to address drug use with their patients [10].
Some of these recommendations may occur within more
informal learning experiences, such as direct contact with
patients with drug problems [11] or through special study
components (SSC). It is essential however that these
recommendations become embedded within the formal
undergraduate and postgraduate curricula in order for
all students to cover the learning objectives and not
just for those who happen to have relevant informal
learning experiences.
This paper describes a national project run over two
phases. Phase one (2005–2007) involved all medical
schools in the UK to develop consensus guidance on
the integration of teaching about alcohol, drugs and
tobacco in the undergraduate medical curricula. Phase
two (2008–2011) focused on the implementation of the
guidance in to the curricula of English medical schools.
In the first phase a survey was undertaken to gather in-
formation about substance misuse teaching and learning.
The second phase focused on mapping substance misuse
teaching within English medical schools thus identifying
perceived and actual teaching occurring in undergraduate
medical curricula. The project did not focus on the infor-
mal teaching that can occur within medical education nor
the number of hours dedicated to the teaching of sub-
stance misuse but aimed to identify the number of actual
teaching sessions that had formal learning objectives relat-
ing to substance misuse.
Methods
The project was conducted in two phases. Phase one
(2005–2007) involved conducting semi-structured inter-
views with key people. The questions asked were informed
by a literature review of substance misuse teaching in
undergraduate medical education and discussions with
experts in the area. The potential interviewees within
each UK medical school were asked if they would
consent to participate in the semi-structured interview
to identify their perceptions of the substance misuse
teaching that occurred in their respective medical schools.
The responses from these interviews facilitated the devel-
opment of a substance misuse toolkit which focused on
the specific learning objectives generally devised for sub-
stance misuse teaching. Phase two involved appointed cur-
riculum co-ordinators mapping the actual teaching and
learning of substance misuse using the toolkit devised
in phase one and more on this has been described in
another paper [12]. The second phase however identi-
fied the actual number of teaching sessions that were
delivered which will be reported here.
Participants
Participants in phase one were either the head of the
undergraduate medical curriculum (such as the Director
of the medical school) or other key people who were re-
sponsible for the major component of teaching about
substance misuse, usually the organiser of the Psychiatry
module. Two researchers identified and contacted po-
tential participants via email or telephone call and 19
participants were recruited (two provided written feed-
back). Participants in phase two were the English med-
ical schools who appointed a curriculum co-ordinator to
map the areas of substance misuse teaching.
Materials
A semi-structured interview was designed during discus-
sions held by specialists forming an expert panel and
conducted with participants in the first phase of the pro-
ject. The interview questions covered curriculum con-
tent, curriculum delivery, assessment, student selected
components and learning materials. Example interview
questions include “Could you describe how teaching and
learning about substance misuse is organised?” (curricu-
lum delivery) and “Are there Student Selected Compo-
nents in the area of substance misuse available to
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students?” (student selected components). The responses
were collated and used by a working group of healthcare
professionals and educators to devise a UK consensus
guidance document on substance misuse teaching in the
undergraduate medical curriculum. To accompany this
document, a substance misuse toolkit was devised that
set out the core aims and learning outcomes for under-
graduate medical curricula. The toolkit focused on bio-
psycho-social models of addiction, professionalism and
self-care, clinical assessments of patients, treatment in-
terventions, specific disease and speciality topics and
epidemiology, public health and society.
Procedure
In phase one, two researchers identified and arranged
semi-structured telephone interviews with consenting
key staff over a period of 15 weeks in 2005 to obtain
feedback on substance misuse teaching. The responses
were then collated and the key aspects were identified
by the two researchers. Using these responses, a toolkit
was used by curriculum co-ordinators in phase two to
identify the exact teaching sessions that featured learn-
ing objectives relating to substance misuse. Curriculum
co-ordinators began collecting this information at differ-
ent time-points over a 12-month period between 2009
and 2011. Due to the different data collection time-points,
some of the information collated during the mapping
process was not available for the deadline of writing re-
ports concerning the project but has since been submitted
and is reported in this paper.
Ethical approval
This project was a review of the current teaching and
learning that occurs within undergraduate medical educa-
tion. All work was conducted based on the Declaration
of Helsinki ethical principles for research involving human
participants. No formal ethical approval was required
from an ethics committee as the interviews were provid-
ing feedback on the medical course and the toolkit was
identifying teaching sessions only that covered the differ-
ent substance misuse learning objectives.
Results
Demographic statistics
Out of 32 UK medical schools, 22 interviews were con-
ducted and ten medical schools provided written re-
sponses to the questions, resulting in feedback being
obtained from all medical schools. During phase two, 18
out of the 19 English medical schools (a 95% response
rate) submitted data from the mapping process.
Phase one
Participants reported substance misuse learning objec-
tives and outcomes existed at the programme level, the
module level and the individual teaching session level.
Although they acknowledged explicit reference to sub-
stance misuse at the programme level might be limited,
specific reference was mentioned in relation to sub-
stance misuse and self-care while implicit reference was
made to the development of an appropriate attitude to
patients. The majority of teaching and learning about
substance misuse were reported to be located within
psychiatry modules, however other disciplines were also
perceived to include teaching on substance misuse. Pri-
mary care and general practice attachments were men-
tioned by nine participants as being one area where
students received substance misuse teaching, and cross-
year teaching such as communication skills, problem-
based learning (PBL), and community based medicine
(n = 9) were also reported to provide substance misuse
learning objectives. Five participants reported that sub-
stance misuse teaching was delivered during public
health modules while eight stated that these issues were
raised directly (and indirectly) in personal and profes-
sional modules or introductory courses. When asked
specifically about student selected components (SSC),
eleven medical schools reported offering at least one
SSC focusing on substance misuse. However, one par-
ticipant described how nearly one-third of SSC topics
offered in their curriculum were related to substance
misuse, suggesting variation amongst medical schools
concerning the number of substance misuse SSCs. As
the aim of this phase was not to identify the number
of hours spent formally teaching substance misuse is-
sues, participants only reported where in the curricu-
lum substance misuse was formally taught.
A range of learning materials were used to support
substance misuse teaching including CD-ROMs, online
resources, handouts, powerpoint presentations, alcohol
information packs and an internet game focusing on
managing alcoholic patients. Assessing students’ know-
ledge of these issues was mainly conducted using Ob-
served Structured Clinical Examination stations (n = 10)
and predominately focused on assessing students’ com-
munication skills when interacting with patients with
substance misuse problems.
Phase two
Analysis of the data gathered during the mapping
process revealed that bio-psycho-social models of addic-
tion had the most number of teaching sessions identified
(n = 958, an average of 53 per medical school), with pro-
fessionalism and self-care having the least number of
teaching sessions (n = 418, an average of 23 per medical
school; Table 1). These figures are higher than those re-
ported elsewhere [12] due to some of the information
becoming available after the initial report of the project
had been written.
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Within the bio-psycho-social models of addiction
theme, defining substance misuse, dependence and ad-
dictive behaviour was the most frequently taught topic
in medical education (n = 291, an average of 16 sessions
per medical school). Demonstrating awareness of the
causes of addiction and describing the chemical absorp-
tion and excretion of addictive drugs were the least fre-
quently covered topic (n = 7 sessions per medical school;
Table 2).
For the professionalism and self-care theme, the topic
of demonstrating a professional attitude was frequently
focused upon (n = 109, an average of 6 sessions per med-
ical school) whereas demonstrating an understanding of
iatrogenic addiction was the least frequently covered topic
(n = 30, an average of 1 session per medical school). When
mapping the teaching that occurs around the clinical as-
sessment of patients with substance misuse problems, co-
ordinators identified 263 teaching sessions (an average of
14 sessions per medical school) covering the major clinical
features of alcohol and drug dependence. Yet only 60 ses-
sions (an average of 3 sessions per medical school) focused
on conducting a psychological assessment of a patients’
readiness to implement change.
Table 2 also shows variation in the number of teaching
sessions focusing on the treatment and interventions
available to people who misuse substances, with the ma-
jority focusing on how to advise a patient appropriately
on reducing or abstaining from using alcohol or tobacco
(n = 319, an average of 17 sessions per medical school).
The least frequently taught topic in this area related to
students ability to demonstrate their awareness of risk
related to needle use and disposal (n = 33, an average of
1 session per medical school). Within the epidemiology,
public health and society theme, learning about the dis-
tribution and determinants of alcohol consumption,
smoking and drug use in both the general and the med-
ical population was the most frequently taught (n = 97,
an average of 5 sessions per medical school). In contrast,
curriculum co-ordinators found little teaching covered
the international policies and strategies in place to limit
the supply and demand of drugs (n = 10, an average of
half a teaching session per medical school).
Finally, many teaching sessions were offered that ad-
dressed specific substance misuse topics such as describ-
ing the link between substance misuse and accidents,
lung disease or mental health (n = 584, an average of 32
sessions per medical school). Few sessions however fo-
cused on making students aware of how substance mis-
use can influence the aetiology of neurological conditions
(n = 52) and the effects of addiction and drug consump-
tion during pregnancy (n = 58), an average of 3 sessions
for both learning objectives per medical school.
Discussion
The above mapping process revealed the areas of sub-
stance misuse teaching and learning that were perceived
to be and were actually covered within medical educa-
tion. Changes have been documented in relation to how
substance misuse is incorporated into the curriculum
[13], and the increase in specific learning objectives spe-
cialising in linking substance misuse to health issues
could reflect an increase in the number of core and
elective modules (such as SSCs, clinical skills, communi-
cation skills etc.) that now include some reference to pa-
tients who misuse substances. Furthermore, the rise in
research relating to substance misuse has provided a
comprehensive evidence base for teaching students good
medical practice [14,15] and has enabled medical educa-
tion to develop both generic and specific substance mis-
use learning objectives.
The most prevalent area covered in the undergraduate
curriculum was bio-psycho-social models of addiction.
The clinical, psychological and social impact of drug mis-
use and dependence has long been accepted as important
for medical students to consider when interacting with pa-
tients and colleagues. Clinical assessment and treatment
interventions are covered comprehensively suggesting stu-
dents are now being given the opportunity to develop the
skills required for interacting with substance misuse in pa-
tients. Students have been found to ask about drug use as
a prevention strategy during these formal clinical assess-
ments [16], suggesting an awareness early on in their edu-
cation of how substances can be used to prevent as well as
treat medical conditions. Identifying the clinical features of
substance dependence is also an important area for stu-
dents as many begin their careers in general practice where
patients misusing prescription drugs can be a problem
[17], therefore the clinical knowledge acquired around the
features, physical effects and treatment strategies of sub-
stance misuse is essential. Additionally, substance misuse
learning objectives that feature within different modules
support the view of educators that these issues are located
in various modules across all years of medical education.
Table 1 The number and average of substance misuse
teaching sessions identified in the general medical
curriculum
Learning outcomes area Number of
teaching sessions
Averaged
(per school)
Bio-psycho-social models of
addiction
958 53
Professionalism and self-care 418 23
Clinical assessment of patients 942 52
Treatment interventions 921 51
Epidemiology, public health and
society
578 32
Specific disease and speciality topics 846 47
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Table 2 The actual number and average of teaching sessions per medical school identified by curriculum co-ordinators
Theme in toolkit Learning outcome Number of formal teaching
sessions with substance
misuse learning objectives
Averaged
(per medical
school)
Bio-psycho-social
models of addiction
1a. Define substance misuse, dependence and addictive behaviour and distinguish between acceptable and problematic use 291 16
1b. Demonstrate awareness of the range of substances that can be misused, the different types and classes of addictive
substances, their alternative and colloquial names and their effects
143 7
1c. Demonstrate awareness of the psychological, social, biological and genetic causes of dependence and addiction, the
interactions between such factors in the individual and the different models used to describe addiction
157 8
1d. Describe the absorption, distribution, excretion and metabolism of drugs of addiction 133 7
1e. Describe the physical effects of addiction, including the key effects of drug addiction on neurotransmitter systems,
mechanisms of drug tolerance and the physiological effects of withdrawal
234 13
Professionalism,
fitness to practice and
students’ own health
2a. Demonstrate a professional attitude towards substance misusers which incorporates a non-judgemental approach and
respect for a patient's autonomy
109 6
2b. Describe the risk factors for substance misuse in themselves, in medical students and in healthcare workers 70 3
2c. Describe the sources of help for students and doctors with drug and alcohol related problems 35 1
2d. Describe how substance misuse problems may affect a healthcare professional’s judgement, performance and care for their
patients
59 3
2e. Describe the need to balance due concern for the health of a colleague with responsibilities for the safety and welfare of
patients
56 3
2f. Outline the role of the GMC and medical schools in ensuring students and doctors’ fitness to practice 59 3
2g. Demonstrate understanding of iatrogenic addiction 30 1
Clinical assessment of
patients
3a. List the major clinical features of alcohol and drug dependence 263 14
3b. Describe the range of clinical outcomes of addiction and discuss the prognosis and management 154 8
3c. Take a focussed drug and alcohol history 134 7
3d. Elicit signs of alcohol or drug misuse through physical and mental state examinations and identify and prioritise medical and
psychosocial problems associated with substance misuse
136 7
3e. Demonstrate appropriate skills for communicating sensitively with patients about substance misuse issues and for dealing
with difficult, aggressive or intoxicated patients, balancing assessment need with their own safety and that of others
105 5
3f. Appropriately order and interpret urine and blood screening tests for drugs of addiction, use standardised screening and
assessment instruments to detect alcohol and drug levels and describe other special investigations and how to interpret results
90 5
3g. Carry out a psychological assessment of a patient’s readiness to implement change 60 3
Treatment
interventions
4a. Describe the basic treatment regimens for various addictions and withdrawal states 134 7
4b. Describe the basis of commonly used therapies for addiction, such as Brief Intervention therapy 66 3
4c. Describe the variety of UK agencies to which patients with addiction problems can be referred and how and where to make
appropriate referrals for treatment
46 2
4d. Advise a patient on risk-reduction strategies for drug use 75 4
4e. Demonstrate awareness of risk related to needle use and disposal for healthcare workers and patients 33 1
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Table 2 The actual number and average of teaching sessions per medical school identified by curriculum co-ordinators (Continued)
4f. Advise a patient appropriately on reducing or abstaining from drinking and smoking and implement a treatment plan with
the patient
319 17
4g. Advise addicted women on how to stabilise/discontinue substance use to minimise impact on foetal and maternal health 48 2
4h. Demonstrate awareness of the need to assess patients’ capacity to consent to treatment 159 8
4i. Describe the impact of substance misuse on concordance with treatment including Discharge Against Medical Advice and
drug interactions
41 2
Epidemiology, public
health and society
5a. Describe UK policies on drug use, drug dispensing and prescribing and on alcohol and smoking 67 3
5b. Describe UK legislation on controlling drugs, alcohol and tobacco, including the legal limits for alcohol and driving and the
recommended maximum limits for alcohol consumption
76 4
5c. Describe UK strategies for the prevention of drug misuse 26 1
5d. Describe international policies and strategies to limit drug supply and demand 10 0.5
5e. Describe the epidemiology of alcohol consumption, smoking, drug misuse in the general population and specifically in
doctors and other healthcare professionals
97 5
5f. Describe the problems associated with self-medication 36 2
5g. Demonstrate awareness of the risks in different work environments and the need for employers to have drug and alcohol
policies
23 1
5h. Describe the effects of addiction on individuals, their families, friends and colleagues in a range of age-groups; from children
and adolescents to older people
69 3
5i. Describe the long-term social consequences of various types of addiction and substance misuse, including the economic
consequences and the links between crime and substance misuse
63 3
5j. Describe the risks to the children of addicted parents including child protection policies and a doctor’s duty to implement
these
59 3
5k. Demonstrate an understanding of the principles of rational prescribing and the use of psycho-active medication 52 2
Specific disease and
speciality topics
6a. Recognising life-threatening complications of substance misuse, including septicaemia, pulmonary emboli and overdose and
be able to carry out appropriate interventions
152 8
6b. Describe and explain the links between substance misuse and accidents; lung disease, specifically smoking; anxiety,
depression, dementia, schizophrenia; self-harm and suicide; heart disease and hypertension; liver disease, pancreatitis and
gastritis; infectious diseases, including HIV and hepatitis B and C; cancers; sleep disorders; weight problems
584 32
6c. Show awareness of substance misuse in the aetiology of neurological conditions including seizures, par aesthesia and stroke 52 3
6d. Describe the effects of addiction, drug and alcohol use on pregnancy 58 3
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Few teaching sessions focused on professionalism, fit-
ness to practice and students’ own health in relation to
substance misuse. One area that was emphasised focused
on developing a professional attitude towards patients
who misuse substances – a positive finding, as formal
teaching programmes that provide access to substance
misusers have been shown to effectively improve med-
ical students’ attitudes towards this patient group [11].
However, there was a lack of teaching focusing on un-
derstanding iatrogenic addiction. The use of analgesic
drugs such as morphine are often effective in reducing
pain yet despite doctors’ propensity to administer these
drugs confidently in clinical environments, they often
have addictive properties and may contribute to the de-
velopment of iatrogenic illness in patients [18]. Reasons
for the lack of understanding regarding iatrogenic addic-
tion include different perceptions of doctors, nurses and
patients regarding pain intensity, a belief that patients
exaggerate their pain in order to obtain more medication
[19] and an underestimation by doctors of the potential
effect of drugs such as sedatives in promoting depend-
ence or addictive behaviour in patients [20]. It is import-
ant therefore to raise awareness of the effects of iatrogenic
addiction in all health professionals, and this could be
integrated into the undergraduate medical curriculum
through SSCs, PBL, and other formal teaching sessions
supporting a bottom-up approach to learning [21].
There are however some limitations to this project
which need to be addressed. First, the project did not
focus on the learning that can occur within informal ex-
periences or via the hidden curriculum, both of which
are important sources of learning for medical students
[9] and it is unclear what informal learning occurs in re-
lation to substance misuse. Secondly, the data was only
collected from English medical schools and did not
cover the curriculum delivered in other parts of the UK.
Thirdly, it is unclear whether the mapping conducted by
the curriculum co-ordinators was consistent across all
participating medical schools and there were no external
checks to identify the accuracy of the mapping process.
Lastly, a formal evaluation of the project was not per-
formed but would have been beneficial to appraise the
effectiveness of conducting this type of research. Future
projects would therefore benefit from addressing these
limitations and investigating the impact of informal
learning experiences on medical students’ knowledge
and understanding of substance misuse issues. Further-
more, future projects of this design would benefit from
including an evaluation process and internal reliability
checks before conducting it in other medical schools
across the UK.
Despite these limitations, one result of the curriculum
mapping process is that co-ordinators were able to im-
plement a variety of changes such as re-writing PBL
learning outcomes to specifically include substance mis-
use, updating library and internet resources, and intro-
ducing lectures and workshops targeting substance
misuse issues. For example, one medical school wrote a
policy in relation to drugs, alcohol and substance misuse
which outlined the regulations and code of conduct for
students to follow during their medical training. This
was written in all module handbooks ensuring students’
awareness of the importance of substance misuse issues.
Some medical schools worked with external agencies to
increase students’ access to people who have substance
misuse problems, initiatives that students reported as
being interesting and conducive to their learning. In
addition to individual changes being implemented at the
different medical schools, substance misuse factsheets
were generated to facilitate students’ learning in relation
to specific issues (e.g. substance misuse and anaesthesia,
substance misuse and pregnancy, substance misuse in
gastroenterology). These could be accessed and used by
all participating medical schools and focused on a wide
range of areas in which substance misuse issues could
arise. They were devised by a group of experts in the
field to ensure that each help pertinent information re-
lating specifically to each topic and were used by some
medical schools to facilitate students’ learning.
A key question now, given the success of the project,
is how best to sustain the positive changes implemented
in the teaching of substance misuse to our future doc-
tors, so that future graduating medical students continue
to be better equipped to deal with substance misuse and
to meet the requirements specified by the GMC. This
project across both phases has enhanced the training
and education of student doctors and has established a
solid basis for substance misuse teaching through the
implementation of UK corporate guidance and improve-
ments in the quality of training of future doctors in English
medical schools. Funding for a third phase has been found
and the aims of this phase are to further develop and build
on the existing network of academic champions/lead per-
son within the medical schools to work on embedding
substance misuse in to teaching through the corporate
curricula and learning materials so as to ensure that the
changes implemented in the teaching of substance misuse
to our future doctors continue to be better equipped to
deal with substance misuse.
Conclusions
To conclude, this project has identified the areas and fre-
quency of formal substance misuse teaching within the
undergraduate medical education. The bio-psycho-social
models of addiction are most frequently covered by med-
ical schools allowing students to focus on the clinical as-
pects of substance misuse. However, one area that is not
frequently covered in the formal curriculum is iatrogenic
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addiction and it is unclear whether this and other
substance misuse issues are addressed during informal
learning experiences. Future research therefore could in-
vestigate the influence of informal learning experiences in
relation to substance misuse as well as how the positive
teaching that currently occurs can be sustained to ensure
graduating medical students are better equipped with the
skills needed to deal with these issues in their future
practice.
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